rat IgM immunocytoma cells (0.01 x 10E6 cells) (for 18 days) then doxorubicin (0.5 mg/kg) (for 7 days)

 rat IgM immunocytoma cells (0.01 x 10E6 cells) (for 18 days) then doxorubicin (1 mg/kg) (for 42 days)

 rat IgM immunocytoma cells (0.01 x 10E6 cells) (for 18 days) then doxorubicin (0.5 mg/kg)

 doxorubicin (0.5 mg/kg) (for 14 days)

 rat IgM immunocytoma cells (0.01 x 10E6 cells) (for 18 days) then doxorubicin (2 mg/kg) (for 7 days)

 doxorubicin (2 mg/kg) (for 7 days)

 doxorubicin (0.5 mg/kg) (for 42 days)

 rat IgM immunocytoma cells (0.01 x 10E6 cells) (for 18 days) then doxorubicin (0.5 mg/kg) (for 56 days)

 doxorubicin (1 mg/kg)

 doxorubicin (2 mg/kg)

 rat IgM immunocytoma cells (0.01 x 10E6 cells) (for 18 days) then doxorubicin (2 mg/kg) (for 14 days)

 rat IgM immunocytoma cells (0.01 x 10E6 cells) (for 18 days) then doxorubicin (0.5 mg/kg) (for 42 days)

 doxorubicin (0.5 mg/kg)

 doxorubicin (0.5 mg/kg) (for 56 days)

 rat IgM immunocytoma cells (0.01 x 10E6 cells) (for 18 days) then doxorubicin (1 mg/kg) (for 14 days)

 rat IgM immunocytoma cells (0.01 x 10E6 cells) (for 18 days)

 rat IgM immunocytoma cells (0.01 x 10E6 cells) (for 18 days) then doxorubicin (0.5 mg/kg) (for 14 days)

 rat IgM immunocytoma cells (0.01 x 10E6 cells) (for 18 days) then doxorubicin (1 mg/kg)

 rat IgM immunocytoma cells (0.01 x 10E6 cells) (for 18 days) then doxorubicin (2 mg/kg)

 rat IgM immunocytoma cells (0.01 x 10E6 cells) (for 18 days) then doxorubicin (1 mg/kg) (for 56 days)

 doxorubicin (1 mg/kg) (for 42 days)

 control condition

 rat IgM immunocytoma cells (0.01 x 10E6 cells) (for 18 days) then doxorubicin (1 mg/kg) (for 7 days)

 doxorubicin (0.5 mg/kg) (for 7 days)

 doxorubicin (1 mg/kg) (for 14 days)

 doxorubicin (1 mg/kg) (for 7 days)